Why women say yes to prenatal diagnosis(*)

Social Science and Medicine

Volumn 45, Issue 7, 1997, Pages 979-989

  Press, Nancy ^a   Browner, C H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abortion; Maternal serum alpha fetoprotein; Prenatal screening; Routinization of medical innovations

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; BLOOD SAMPLING; COMPREHENSION; DEVELOPMENTAL DISORDER; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HUMAN EXPERIMENT; MATERNAL SERUM; MEDICOLEGAL ASPECT; NEURAL TUBE DEFECT; NORMAL HUMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; UNITED STATES;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CALIFORNIA; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES RESEARCH; HUMANS; MASS SCREENING; NEURAL TUBE DEFECTS; PATIENT ACCEPTANCE OF HEALTH CARE; PRENATAL DIAGNOSIS;

EID: 0030803565     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(97)00011-7     Document Type: Article

References (49)

1. Abuelo, D. N. et al. (1991) Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenatal Diagnosis 11, 381-385.
2. American College of Obstetrics and Gynecology (ACOG) (1985) Professional liability implications of AFP tests. DPL Alert.
3. Annas, G. J. (1985) Is a genetic screening test ready when the lawyers say it is?. Hastings Center Report 15, 16-18.
4. Bennet, M. J., Gau, G. S. and Gau, D. W. (1980) Women's attitudes to screening for neural tube defects. British Journal of Obstetrics and Gynaecology 87, 370-371.
5. Berne-Frommel, K., Josefson, G. and Kjessler, B. (1984) Who declines from antenatal serum alpha fetoprotein screening - and why?. Acta Obstetrica Gynecologica 63, 687-691.
6. Brock, D. H. J. and Sutcliffe, R. G. (1972) Lancet ii, 197.
7. Brock, D. H. J., Bolton, A. E. and Monaghan, J. M. (1973) Prenatal diagnosis of anencephaly through maternal serum alpha-fetoprotein measurement. Lancet ii, 923-924.
8. Brown, P. (ed.) (1989) Perspectives in Medical Sociology. Waveland, Prospect Heights, IL.
9. Browner, C. H. and Press, N. (1996) The production of authoritative knowledge in American prenatal care. Medical Anthropology Quarterly 10, 141-156.
10. Burton, B. K. et al. (1985) The psychological impact of false positive elevations of maternal serum alpha-fetoprotein. American Journal of Obstetrics and Gynecology 151, 77-82.
11. Byrne-Essif, K., Naber, J. M. and Colmorgen, G. H. C. (1988) Acceptance of maternal serum alpha fetoprotein screening in Wilmington hospital's obstetrical clinic. Delaware Medical Journal 60, 569-571.
12. Chalmers, I., Enkin, M. and Keirse, M. J. N. C. (1989) Effective Care in Pregnancy and Childbirth. Volume 1: Pregnancy, Parts 1-4. Oxford University Press, Oxford.
13. Clarke, A. (1991) Is non-directive genetic counseling possible?. Lancet 338, 998-1001.
14. Dembert, M. L. et al. (1983) Women's attitudes toward the serum alpha-fetoprotein test. Connecticut Medicine 47, 525-529.
15. Deukmejian, G., Allenby, C. L. and Kizer, K. W. (1990) A Report to the Legisture: Review of Current Genetic Programs. State of California, Health and Welfare Agency, Department of Health Services, Genetic Disease Branch.
16. Doran, T. A. et al. (1987) Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project. CMAJ 137, 285-293.
17. Duster, T. (1990) Backdoor to Eugenics. Routledge, New York.
18. Evans, M. I. and Johnson, M. P. (1992) Prenatal diagnosis in the '90 s, a symposium . Journal of Reproductve Medicine 37, 387-388.
19. Evans, M. I. et al. (1987) Establishment of a collaborative university-commercial maternal serum alpha-fetoprotein screening program: a model for a tertiary center outreach. American Journal of Obstetrics and Gynecology 156, 1441-1449.
20. Evans, M. I., Bottoms, S. F. and Carlucci, T. (1988) Determinants of altered anxiety after abnormal maternal serum alpha-fetoprotein screening. American Journal of Obstetrics and Gynecology 59, 1501-1504.
21. Faden, R. R. et al. (1987) Prenatal screening and pregnant women's attitudes toward the abortion of defective fetuses. American Journal of Public Health 77, 288-289.
22. Foltz, A. and Kelsey, J. L. (1982) The annual pap test: a dubious policy success. In Technology and the Future of Health Care, Milbank Reader, ed. J. B. Milbank, Vol. 8, pp. 331-367. MIT Press, Cambridge, MA.
23. Gardner, M. A., Burton, B. K. and Johnson, A. M. (1981) Maternal serum alpha-fetoprotein screening: a report of the Forsyth County Project. American Journal of Obstetrics and Gynecology 140, 250-253.
24. Grant, S. (1992) Coordinator, MSAFP Screening Program, University of Iowa. Personal communication.
25. Green, J. M., Snowdon, C. and Statham, H. (1993) Pregnant women's attitudes to abortion and prenatal screening. Journal of Reproductive and Infant Psychology 11, 31-39.
26. Greenberg, F. (1988) The impact of MSAFP screening on genetic services, 1984-1986. American Journal of Medical Genetics 31, 223-230.
27. Holtzman, N. A. (1989) Proceed with Caution: Predicting Genetic Risks in the Recombinant DNA Era. Johns Hopkins University Press, Baltimore.
28. Holtzman, N. A. (1991) What drives neonatal screening programs?. New England Journal of Medicine 325, 802-804.
29. Hubbard, R. (1986) Eugenics and prenatal testing. International Journal of Health Services 16, 227-242.
30. Kay, M. A. (1980) Mexican, Mexican American, and Chicana childbirth. In Twice a Minority: Mexican American Women, ed. M. B. Melville, pp. 52-65. Mosby, St. Louis.
31. Kyle, D., Cummins, C. and Evans, S. (1988) Factors affecting the uptake of screening for neural tube defects. British Journal of Obstetrics and Gynaecology 95, 560-564.
32. Lazarus, E. (1994) What do women want? Issues of choice, control, and class in pregnancy and childbirth. Medical Anthropology Quarterly 8, 25-46.
33. Lippman, A. (1989) Prenatal diagnosis: reproductive choice? reproductive control? In The Future of Human Reproduction, ed. C. Overall, pp. 182-194. Women's Press, Toronto.
34. Lippman, A. and Evans, J. A. (1987) What about the low side?. Canadian Medical Journal 136, 801-804.
35. Macri, J. N., Haddow, J. E. and Weiss, R. R. (1979) Screening for neural tube defects in the United States: a summary of the Scarborough Conference. American Journal of Obstetrics and Gynecology 133, 119-125.
36. Madlon-Kay, J. J. et al. (1992) Maternal serum alpha-fetoprotein testing: physician experience and attitudes and their influence on patient acceptance. Journal of Family Practice 35, 395-400.
37. Marteau, T. M. et al. (1989) Factors influencing the uptake of screening for open neural tube defects and amniocentesis to test for Down's Syndrome. British Journal of Obstetrics and Gynaecology 96, 739-748.
38. Martin, E. (1987) The Woman in the Body. Beacon, New York.
39. McKinlay, J. B. (1982) From "promising report" to "standard procedure:" seven stages in the career of a medical innovation. In Technology and the Future of Health Care, Milbank Reader, ed. J. B. Milbank, Vol. 8, pp. 233-270. MIT Press, Cambridge, MA.
40. Meaney, F. J., Riggle, S. M. and Cunningham, G. C. (1993) Providers and consumers of prenatal genetic testing services: what do the national data tell us?. Fetal Diagnosis and Therapy 8(S1), 18-27.
41. Mechanic, D. (1986) From Advocacy to Allocation: The Evolving American Health Care System. Free Press, New York.
42. Merkatz, I. R. et al. (1984) An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. American Journal of Obstetrics and Gynecology 148, 886-894.
43. Press, N. A. and Browner, C. H. (1993) "Collective fictions": similarities in reasons for accepting MSAFP screening among women of diverse ethnic and social class backgrounds. Fetal Diagnosis and Therapy 8(S1), 97-106.
44. Roberts, C. J. et al. (1983) The efficacy of a serum screening service for neural-tube defects: the South Wales experience. Lancet 11 June, 1315-1318.
45. Rothman, B. K. (1987) The Tentative Pregnancy: Prenatal Diagnosis and the Future of Motherhood. Viking Penguin, New York.
46. Sanden, M. L. and Bjurulf, P. (1988) Pregnant women's attitudes and knowledge in relation to access to serum alpha-fetoprotein test. Scandanavian Journal of Social Medicine 16, 97-204.
47. Sikkink, J. (1990) Patient acceptance of prenatal alpha-fetoprotein screening: a preliminary study. Family Practice Journal 10, 123-131.
48. United Kingdom Collaborative Study on Alpha-Fetoprotein in Relation to Neural Tube Defects(1977) Maternal serum alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Lancet 1, 1323-1332.
49. Waitzkin, H. (1983) The Second Sickness: Contradictions of Capitalist Health Care. Free Press, New York.